Scienmag

SEPTEMBER 24, 2020

DrBioRight uses natural-language interface to facilitate intuitive data analysis for broader research community Credit: The University of Texas MD Anderson Cancer Center HOUSTON — A new data analysis tool developed by researchers at The University of Texas MD Anderson Cancer Center incorporates a user-friendly, natural-language interface to allow (..)

Bioinformatics 48

Bioinformatics Big Data Research Development 48

Rethinking Clinical Trials

APRIL 26, 2023

Dr. Semler is an assistant professor of medicine and bioinformatics and the medical director of the Center for Learning Healthcare in the Vanderbilt Center for Clinical and Translational Research. ” The Grand Rounds session will be held on Friday, April 28, 2023, at 1:00 pm eastern. Join the online meeting.

Trials 130

Trials Bioinformatics Clinical Trials Clinical Trials 130

Pharmaceutical Technology

FEBRUARY 17, 2023

Oncology-focused bioinformatics firm M2GEN has entered a multi-year strategic collaboration with Zephyr AI to identify treatments and cures for cancer patients. This partnership not only holds the potential to chart a new era of drug discovery and precision medicine but to save innumerable lives.”

Bioinformatics 147

Bioinformatics Production Clinical Trials Clinical Trials 147

BioTech 365

JULY 7, 2021

Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors Former Magenta Therapeutics and Foundation Medicine CFO Jason Ryan to Join Sema4 Board of Directors STAMFORD, Conn.–(BUSINESS

Medicine 52

Medicine Bioinformatics 52

Pharmaceutical Technology

JUNE 28, 2022

The latest research is part of the consortium of a new antiviral drug development centre named Center for Antiviral Medicines and Pandemic Preparedness (CAMPP), to be led by Scripps Research. The team’s work will be based on the prior research of Structural Bioinformatics Constellation Endowed chair Dr Montelione.

Development 147

Development Bioinformatics Drugs Allergies 147

Scienmag

JUNE 28, 2021

McIndoe, bioinformatics expert and associate director of the Center for Biotechnology and Genomic Medicine at the Medical College of Georgia, is leading a dynamic, new $6.2 Credit: Michael Holahan, Augusta University Dr. Richard A.

Bioinformatics 75

Bioinformatics Research Genome Genomics 75

Medical Xpress

NOVEMBER 8, 2022

A team of researchers at Indiana University School of Medicine has developed specialized bioinformatics software designed to identify rare genetic variants in whole-genome sequencing studies. Zilin Li, Ph.D.,

Genetics 75

Genetics Bioinformatics Genome Genomics 75

Scienmag

MARCH 25, 2021

Javier Cote-Sierra partnered with an AI-driven drug discovery company, Insilico Medicine to tackle cancer and autoimmune diseases Credit: Insilico Medicine Thursday, 25th of March 2021 (5:00AM EST) — Today, AllianThera Biopharma (ATB), a Suzhou, China-based startup focusing on inventing and developing innovative medicines for […].

Medicine 76

Medicine Development Drugs Bioinformatics 76

Drug Discovery World

FEBRUARY 17, 2023

A new multi-year strategic partnership between M2GEN and Zephyr AI will leverage clinicogenomic data, bioinformatics, and artificial intelligence to accelerate drug discovery and expanded use cases for oncology treatments. million lives around the world,” said Grant Verstandig, Co-Founder and Executive Chairman of Zephyr AI.

Bioinformatics 52

Bioinformatics Drugs Licensing Licensing 52

Scienmag

MARCH 16, 2021

Physicians and scientists highlight the importance of longevity medicine education and collaborate on the first longevity medicine course for physicians Credit: © Mary Mitina 16th of March, Tuesday, 2021 — Longevity medicine is a rapidly evolving branch of preventative precision medicine that is specifically focused on promoting healthspan and (..)

Medicine 52

Medicine Scientist Development Bioinformatics 52

Drug Discovery World

FEBRUARY 17, 2023

The drug discovery sector is feeling the love this Valentine’s week, with several new research collaborations bringing together a range of expertise and advanced bioinformatics, automation and artificial intelligence technologies to speed up the development of new treatments.

Bioinformatics 52

Bioinformatics Drugs Genome Genomics 52

Scienmag

JUNE 22, 2021

Credit: Insilco June 22, 2021, New York / Hong Kong — Insilico Medicine, a global leader in end-to-end artificial intelligence for target discovery, small molecule chemistry, and clinical development, announced that it has closed a $255 million from biotechnology experts to progress Insilico Medicine’s current therapeutic programs into (..)

Medicine 55

Medicine Clinical Trials Clinical Trials Clinical Development 55

Scienmag

JANUARY 27, 2021

In a paper published in Evolutionary Bioinformatics, Illinois researchers show COVID-19 cases and mortality rates, among other […]. . – With cities around the globe locking down yet again amid soaring COVID-19 numbers, could seasonality be partially to blame? New research from the University of Illinois says yes.

Bioinformatics 95

Bioinformatics Research Genetics Medicine 95

Scienmag

MARCH 15, 2021

For their study, the team led by bioinformatics professor Andreas Keller and his doctoral student […]. Credit: Oliver Dietze In their study, which is now published in the journal Nature Aging, they show that the level of non-coding RNAs in the blood of a Parkinson’s patient can be used to track the course of the disease.

Bioinformatics 92

Bioinformatics Doctors Doctor Genetics 92

Drug Discovery World

SEPTEMBER 29, 2023

AI-driven drug discovery company Insilico Medicine and the University of Cambridge have discovered an approach to identify therapeutic targets for human diseases associated with protein phase separation (PPS). By working with Insilico Medicine, we have provided a roadmap for researchers to navigate this complex terrain.”

Protein 67

Protein Bioinformatics Medicine Engineer 67

XTalks

APRIL 21, 2023

WGS remains at the core of developing personalized medicine against cancer as it provides valuable information for cancer etiology and progression. Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS.

Genome 97

Genome Genomics Bioinformatics Genetics 97

Scienmag

NOVEMBER 12, 2020

In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental mammal genomes, bringing the worldwide total to more than 250 In a study that has unprecedented implications to advance both medicine and biodiversity conservation, researchers have sequenced 131 new placental (..)

Biobanking 41

Biobanking Medicine Genome Genomics 41

Scienmag

MAY 4, 2021

Mohsin Jafri, Director, Neuroscience Program; Professor Bioinformatics/Computational Biology, is studying cancer drug susceptibility. This technology may be applied to data extracted from the molecular […].

Bioinformatics 72

Bioinformatics Drugs Genetics Development 72

Scienmag

FEBRUARY 8, 2021

Researchers at Uppsala University have tested the bioinformatic predictions made by another research group and have identified receptors that could be important players in the process. The molecular details of how SARS-CoV-2 enters cells and infects them are still not clear.

Bioinformatics 75

Bioinformatics Research Allergies Medicine 75

Scienmag

MAY 14, 2021

The research, which relied on expertise spanning from breast cancer biology through to bioinformatics, measured gene expression in single cells taken from healthy women and cancerous breast tissue, including […].

Gene Expression 63

Gene Expression Bioinformatics Gene Research 63

Drug Discovery World

AUGUST 29, 2022

will be discussing The Role of AI and Automation in Personalised Medicine: How can AI Help in The Post Drug Discovery Process.?? . Dr Anvar was a senior scientist before joining OKRA, serving as the principal investigator of preclinical personalised medicine. Yahya Anvar, Head of Data Science Okra.AI

Drugs 52

Drugs Bioinformatics Medicine Scientist 52

pharmaphorum

MARCH 19, 2021

As data and digital technology become vital to every aspect of life sciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. According to an article by Stephens, Zachary D.,

Bioinformatics 59

Bioinformatics Drugs Genome Genomics 59

Scienmag

SEPTEMBER 7, 2020

Credit: Felix Petermann, MDC Hundreds of innovators, research pioneers, clinicians, industry leaders and policy makers from all around Europe are united by a vision of how to revolutionize healthcare.

Medicine 58

Medicine Research Bioinformatics Allergies 58

Drug Discovery World

MAY 16, 2023

The company’s DNA-based platform is being developed to address manufacturing challenges associated with the production of recombinant adeno-associated virus (rAAV) vectors used to produce advanced therapy medicinal products (ATMPs).

Production 52

Production Gene Therapy Gene Bioinformatics 52

Rethinking Clinical Trials

FEBRUARY 28, 2024

            Speakers Adrian Hernandez, MD Executive Director, Duke Clinical Research Institute Vice Dean, Duke University School of Medicine Christopher J.

Clinical Trials 141

Clinical Trials Clinical Trials Trials Clinical Research 141

pharmaphorum

JULY 20, 2022

The two organisations have previously collaborated on the creation of three cancer therapeutics companies, including bacterial delivery system developer Neobe therapeutics, oncolytic virus therapy company Stratosvir, and bioinformatics specialist Enedra.

Research 84

Research Bioinformatics Gene Therapy Medicine 84

pharmaphorum

AUGUST 10, 2021

The three-year project – led by respiratory medicine expert Dr Timothy Hinks from the Oxford University Respiratory Medicine Unit – will use whole-genome sequencing of around 500 patients with severe asthma, comparing their gene sequences with control subjects who don’t have asthma.

Gene Sequencing 116

Gene Sequencing Bioinformatics Gene Genome 116

pharmaphorum

JULY 5, 2022

Cell therapy specialist Mogrify has struck a deal with Japanese drugmaker Astellas to look at ways to deploy regenerative medicine to treat hearing loss caused by factors such as chronic exposure to loud noises. An estimated 1.57

In-Vivo 110

In-Vivo Bioinformatics Genetics Licensing 110

Scienmag

MAY 19, 2021

Proprietary bioinformatics, paired with comprehensive clinical curation results in reporting that defines clinically actionable, FDA-approved, and clinical trial drug options for the management of the patient’s cancer.

Genome 41

Genome Genomics Bioinformatics FDA Approval 41

Drug Discovery World

DECEMBER 7, 2023

A cross-sector working group of MND experts was convened by MND Association and My Name’5 Doddie Foundation and coordinated by Medicines Discovery Catapult throughout 2022. million funding call from LifeArc, which aims to identify medicines used in other diseases and repurpose them for MND. The Guiding Principles underpin a new £5 ($6.2)

Drugs 52

Drugs Bioinformatics Clinical Trials Clinical Trials 52

Drug Discovery World

NOVEMBER 30, 2023

Kimryn Rathmell has been chosen as the 17 th director of the National Cancer Institute (NCI), bringing her experience as leader of the Department of Medicine at the Vanderbilt University Medical Center and Physician-in-Chief at the Vanderbilt University Adult Hospital and Clinics.

Drugs 52

Drugs Genome Genomics Bioinformatics 52

Drug Discovery World

NOVEMBER 17, 2022

The findings, from the Icahn School of Medicine at Mount Sinai in New York and published in the journal Cell Reports Medicine , may also lead to new therapeutic targets. Researchers have identified 35 genes associated with long-term Lyme disease that could potentially be used as biomarkers to diagnose patients with the condition. .

Genetics 52

Genetics RNA Immune Response Bioinformatics 52

Drug Discovery World

JULY 26, 2023

An industry overview of the role of the microbiome in precision medicine, and its interplay with research tools, diagnostics, and therapeutic development. But what advancements are taking place within microbiome-based precision medicine and how is it being used within oncology?

Medicine 52

Medicine Genome Genomics Bioinformatics 52

Drug Discovery World

NOVEMBER 7, 2022

In 2018, the UK’s department of health announced an NHS Genomic Medicine Service, which allows patients with rare diseases to have their entire genetic code read in the hope of providing a much-needed diagnosis. Context . Consequently, the UK has established itself at the forefront of diagnostic whole genome sequencing.

Genome 52

Genome Genomics Genetics Genetic Disease 52

pharmaphorum

MAY 27, 2022

This is the second in a two-part series examining how pharma can embrace the DEI agenda to create more effective medicines through more representative clinical trials. data processing systems that support bioinformatics modelling) and digital record systems (e.g. You can read part one of this article here. About the interviewees.

Clinical Trials 80

Clinical Trials Clinical Trials Trials Packaging 80

Drug Discovery World

OCTOBER 20, 2023

The acquisition of Olink underscores the profound impact that proteomics is having as our customers continue to advance life science research and precision medicine,” said Marc Casper, Chairman, President and Chief Executive Officer of Thermo Fisher.

Drugs 52

Drugs Antibody DNA Gene Therapy 52

Drug Discovery World

DECEMBER 26, 2023

Donidalorsen is an investigational ligand-conjugated antisense (LICA) medicine designed to target the prekallikrein, or PKK, pathway. We are excited to collaborate with Otsuka given their proven results in bringing rare disease medicines to patients in Europe,” said Brett Monia, Ionis Chief Executive Officer.

Drugs 52

Drugs Development Medicine Bioinformatics 52